Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Freiburg ZNS-NHL Study
DRKS00003748Phase 2Completed
- Sponsor
- Universitätsklinikum Freiburg
- Start
- May 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methotrexate, cytarabine, thiotepa, carmustine, dexamethasone and 2 more in primary central nervous system lymphoma (PCNSL) and diffuse large B-cell lymphoma (DLBCL), sponsored by Universitätsklinikum Freiburg. Started May 2012; status: completed.
02
Drugs
methotrexatecytarabinethiotepacarmustinedexamethasone
03
Conditions
primary central nervous system lymphoma (PCNSL)diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on DRKS00003748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003748.